Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report Post date November 15, 2022 ← Combined Orthokeratology with Atropine for children with Myopia: A Meta-analysis → Higher order aberrations, refractive error development and myopia control: a review
